在保障研究的科学性和伦理合理性过程中, 伦理审查已经成为开展生物医学研究的国际社会通则。近年来随着我国中医药事业的发展，伦理审查工作得到了充分重视。依托国家中医药管理局“国家中医药临床研究基地”建设项目，按照国家中医药管理局伦理平台建设要求，本院加强了伦理平台建设工作，通过开展同行间的学习交流，强化人员培训，提高伦理审查水平，为中医临床研究提供支撑和保障。

In order to ensure the science and rationality of the research, ethical review has been the general principles of the international community before biomedical research. Along with the development of Chinese medicine in China, the Chinese government has paid close attention to the construction of ethical review in recent years. Relying on the State Clinical Research Center of Chinese Trial Program Affiliated to State Administration of Traditional Chinese Medicine of the People's Republic of China, our hospital has some experiences in the construction of ethical review platform. The academic exchanges and strengthening of personnel training can increase the ethical review level in order to provide supports and insurance for the Chinese medicine clinical research.

科学技术部国家“重大新药创制”科技专项（2012ZX09303-017-002）：中药新药临床评价研究技术平台建设——中药临床试验研究平台，总课题负责人：李国信，子课题负责人：冷向阳；国家中医药管理局中医临床研究基地建设，负责人：宋柏林。